Fibrinogen: A Clotting Factor and Inflammation Marker in One

Fibrinogen (factor I) is a large protein made only in the liver. When you cut yourself, thrombin cleaves it into fibrin monomers that polymerize into the structural mesh of the clot. Without enough fibrinogen, clots cannot form properly and bleeding becomes hard to stop.

It is also the biggest single acute-phase reactant by mass. Inflammatory cytokines (IL-6 most of all) drive the liver to crank out more, and plasma levels can double or triple within days of a major insult. Most of the increased plasma viscosity and red cell rouleaux behind a high ESR is fibrinogen at work. The two markers move in lockstep in chronic inflammation.

The standard "fibrinogen activity" assay measures functional clotting capacity (Clauss method). A separate "fibrinogen antigen" assay measures absolute concentration. For most clinical purposes, the activity assay is what is reported and what matters.

Standard adult reference range:

• Normal: 200 to 400 mg/dL (2.0 to 4.0 g/L).
• Low: below 200 mg/dL. Bleeding risk rises as the level falls.
• Critically low: below 100 mg/dL. Significant bleeding risk; cryoprecipitate is often required during active bleeding.
• Mildly elevated: 400 to 600 mg/dL. Chronic inflammation, smoking, oral estrogens, pregnancy, age.
• Markedly elevated: above 600 mg/dL. Strong acute-phase response or significant chronic disease.

Fibrinogen drifts up with age and runs slightly higher in women than men. Pregnancy roughly doubles it by the third trimester (typically 400 to 600 mg/dL). A reading of 250 in a third-trimester patient looks "normal" on the lab printout but is actually low and worth flagging.

Source: standard coagulation reference values; varies by lab and assay.

Inflammation and infection

The most common reason for an elevated fibrinogen is the acute-phase response. Anything that bumps CRP and ESR will usually bump fibrinogen: bacterial infection, surgery, trauma, autoimmune flare, malignancy. The level rises within 24 to 48 hours of the trigger and falls slowly over weeks.

Chronic low-grade inflammation

Persistent mild elevation (450 to 600 mg/dL) without an obvious acute illness usually points to chronic processes:

• Smoking. Active smokers run fibrinogen 25 to 50 mg/dL higher than non-smokers.
• Obesity, especially with metabolic syndrome.
• Diabetes.
• Chronic kidney disease.
• Rheumatoid arthritis, psoriasis, inflammatory bowel disease.
• Untreated periodontal disease.

Cardiovascular and thrombotic risk

High fibrinogen is an independent cardiovascular risk factor in several large prospective studies (Framingham, ARIC, PROCAM). The mechanism makes sense: more fibrinogen means thicker clots, faster aggregation, and a more inflammatory vascular environment. The effect size is comparable to a moderate elevation in LDL.

The clinical translation has been messier. Fibrinogen is almost never targeted directly with drugs. Treating the underlying drivers (smoking cessation, weight loss, statin therapy, control of inflammatory disease) lowers fibrinogen as a side effect. So the practical use of a high fibrinogen is to motivate those interventions, not to chase the number itself.

Pregnancy and oral estrogen

Pregnancy roughly doubles fibrinogen by the third trimester (typically 400 to 600 mg/dL). Oral contraceptives and oral estrogen replacement raise it by 20 to 40%. These elevations are physiologic and reverse with cessation or delivery.

Other causes

Early MI, nephrotic syndrome, malignancy (especially with concurrent inflammation), and the first days after major surgery. All expected, all explainable.

Low fibrinogen is far more clinically urgent than high fibrinogen. Below 100 mg/dL, hemostasis is meaningfully impaired.

Disseminated intravascular coagulation (DIC)

The classic and most dangerous cause. Massive activation of coagulation burns through fibrinogen, platelets, and other factors faster than the liver can replace them, producing both thrombosis and bleeding at the same time. Triggers: sepsis, obstetric emergencies (placental abruption, amniotic fluid embolism, severe preeclampsia/HELLP), major trauma, hematologic malignancies (especially APL), severe burns. Falling fibrinogen with rising D-dimer in a critically ill patient is DIC until proven otherwise.

Severe liver disease

The liver is the only source, so cirrhosis and acute liver failure produce low levels. In end-stage liver disease, fibrinogen below 100 is a marker of severe synthetic dysfunction and predicts high bleeding risk during procedures.

Massive bleeding and dilutional coagulopathy

Major hemorrhage with crystalloid resuscitation dilutes fibrinogen quickly. In modern trauma protocols, it is often the first factor to fall below hemostatic thresholds. That is why early cryoprecipitate or fibrinogen concentrate is now part of standard massive transfusion protocols.

Congenital fibrinogen disorders

Afibrinogenemia (essentially zero), hypofibrinogenemia (low), and dysfibrinogenemia (functionally abnormal) are rare inherited conditions. They usually present in childhood with bleeding, abnormal clotting, or both. A persistently low fibrinogen in a healthy young adult with a bleeding history should prompt a hematology referral.

Medications

Direct thrombin inhibitors, fibrinolytic therapy (tPA), and L-asparaginase (leukemia treatment) all lower fibrinogen, sometimes substantially. Check the medication list before chasing a low value.

Fibrinogen has a half-life of 3 to 5 days. Longer than CRP (about 19 hours), shorter than albumin (3 weeks). That intermediate tempo is useful. Fibrinogen integrates inflammation over about a week, smoothing the day-to-day noise of CRP without becoming as inertial as albumin.

In practice:

• Acute setting. Track alongside CRP for major infection or post-op inflammation. Fibrinogen rises more slowly and falls more slowly.
• Critical care / DIC. Track with platelets, PT, aPTT, and D-dimer. Fibrinogen drifting toward 100 to 150 in a sick patient is a red flag.
• Chronic inflammation. Fibrinogen, CRP, and ferritin together give a more reliable picture than any single one. ESR rises and falls in lockstep with fibrinogen.
• Cardiovascular trend. A baseline that drifts down 50 to 100 mg/dL over a year of smoking cessation, weight loss, and exercise is real cardiovascular benefit, even though fibrinogen is rarely the explicit target of therapy.

• Below 100 mg/dL with active bleeding. Hemostatic emergency. Cryoprecipitate or fibrinogen concentrate is typically required to reach a safe level (usually 150 to 200 mg/dL, higher in obstetric settings).
• Falling fibrinogen with rising D-dimer in a critically ill patient. Assume DIC and treat the trigger urgently.
• Below 200 mg/dL pre-procedure. Discuss with surgery and anesthesia. Correction may be needed before high-bleeding-risk operations.
• Persistently above 600 mg/dL without a clear acute illness. Workup for chronic infection, autoimmune disease, malignancy, or smoking-related inflammation. Lower it by fixing the underlying cause.
• Persistently mildly elevated (450 to 600) with cardiovascular risk factors. Use as motivation for smoking cessation, weight loss, exercise, and standard cardiovascular risk reduction. Not a target on its own.

• PT and aPTT. The standard coagulation panel. Both prolong as fibrinogen falls below ~100. The pattern helps localize the defect.
• D-dimer. Fibrin breakdown product. Rising D-dimer with falling fibrinogen is the DIC pattern.
• Platelets. Also consumed in DIC. Falling fibrinogen, falling platelets, and rising D-dimer in a sick patient is the classic DIC fingerprint.
• CRP. Faster acute-phase reactant. Rises and falls quicker than fibrinogen, and clarifies whether elevation is acute or chronic.
• ESR. Driven mostly by fibrinogen. The two essentially track each other in chronic inflammation.
• Albumin. A negative acute-phase reactant. Moves the opposite way in inflammation. The albumin-to-fibrinogen ratio helps gauge chronic inflammatory burden.
• Liver function tests (ALT, AST, bilirubin, INR). Needed when low fibrinogen could reflect synthetic liver failure.